Y-mAbs Therapeutics, Inc. (YMAB) NASDAQ

3.82

-0.345(-8.29%)

Updated at May 14 12:34PM

Currency In USD

Valuation

Market Cap347.1M
Enterprise Value280.68M
P/E Ratio-6.65
PEG Ratio-1.48
Price/Sales Ratio2.12
Price/Book Ratio2.1
Enterprise/Revenue1.45
Enterprise/EBITDA-4.22

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.32
Operating Margin-0.35

Management Effectiveness

Return On Assets-0.25
Return On Equity-0.31

Income Statement

Revenue87.69M
Revenue/Share1.97
Gross Profit72.43M
EBITDA-30.67M
Net Income-29.67M
Diluted EPS-0.67

Balance Sheet

Total Cash60.31M
Total Cash/Share1.34
Total Debt603,000
Total Debt/Equity0.01
Current Ratio4.77
Book Value Per Share1.98

Price History

52-Week Change-64.81
52-Week High16.11
52-Week Low3.76
Moving Average 50 Days4.59
Moving Average 200 Days9.31

Statistics

Average Volume317,816
Shares Outstanding45.28M
% Held by Institutions64.43

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A